Karen Ling - 17 Aug 2021 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role: Director
Signature: /s/ Karen Ling
Issuer symbol: TXMD
Transactions as of: 17 Aug 2021
Net transactions value: +$25,084
Form type: 4
Filing time: 19 Aug 2021, 16:31:26 UTC
Previous filing: 12 Aug 2021
Next filing: 27 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXMD	Common Stock	Purchase	$25,084	+33,445	+35%	$0.7500	130,309	17 Aug 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions with prices ranging from $0.746 to $0.748 for an average weighted purchase price of $0.75. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions with prices ranging from $0.746 to $0.748 for an average weighted purchase price of $0.75. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.